Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 18 pseudogene 39 (KRT18P39) is one of many *processed pseudogenes* found in the human genome that are related to the functional **keratin 18** gene (KRT18), a type I intermediate filament expressed in epithelial tissues[5][7][6]. As a pseudogene, KRT18P39 does not encode a functional protein, nor does it play a known direct biological or pathological role. There are at least 77 KRT18-related pseudogenes dispersed throughout the human genome, and none of these contain an intact reading frame or are known to be functional[5][7]. The gene is not listed as a drug target, does not encode a receptor or enzyme, nor is it relevant for cellular signaling, disease, or therapy. The existence of these pseudogenes is a result of genetic duplication and retrotransposition events and they are considered nonfunctional "genomic fossils"[5][7]. The functional gene *keratin 18* (KRT18) is an important protein in epithelial biology and cancer, and is sometimes confused with its pseudogenes[1][4]. KRT18 plays roles in cell structure, apoptosis, and serves as a disease biomarker. However, this is **not** applicable to KRT18P39. There is no evidence that any pseudogene copy, including KRT18P39, acts as a therapeutic target, disease contributor, or biomarker[5][6][7]. In summary, **keratin 18 pseudogene 39** is a nonfunctional genomic copy of an important epithelial gene and does not serve as a valid therapeutic or research target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 18 pseudogene 39 (KRT18P39).